Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 119191193 | 11919119 | 3 | F | 20141218 | 20160729 | 20160115 | 20160912 | PER | US-JNJFOC-20151207384 | JANSSEN | 62.00 | YR | A | F | Y | 0.00000 | 20160912 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 119191193 | 11919119 | 1 | SS | XARELTO | RIVAROXABAN | 1 | Oral | 15 MG TWICE A DAY | Y | U | 0 | 15 | MG | TABLET | |||||
| 119191193 | 11919119 | 2 | SS | XARELTO | RIVAROXABAN | 1 | Oral | Y | U | 0 | TABLET | ||||||||
| 119191193 | 11919119 | 3 | SS | XARELTO | RIVAROXABAN | 1 | Oral | Y | U | 0 | TABLET | ||||||||
| 119191193 | 11919119 | 4 | SS | XARELTO | RIVAROXABAN | 1 | Oral | Y | U | 0 | TABLET | ||||||||
| 119191193 | 11919119 | 5 | SS | XARELTO | RIVAROXABAN | 1 | Oral | 15 MG TWICE A DAY | Y | U | 0 | 15 | MG | TABLET | |||||
| 119191193 | 11919119 | 6 | SS | XARELTO | RIVAROXABAN | 1 | Oral | Y | U | 0 | TABLET | ||||||||
| 119191193 | 11919119 | 7 | SS | XARELTO | RIVAROXABAN | 1 | Oral | Y | U | 0 | TABLET | ||||||||
| 119191193 | 11919119 | 8 | SS | XARELTO | RIVAROXABAN | 1 | Oral | Y | U | 0 | TABLET | ||||||||
| 119191193 | 11919119 | 9 | PS | XARELTO | RIVAROXABAN | 1 | Oral | 15 MG TWICE A DAY | Y | U | 202439 | 15 | MG | TABLET | |||||
| 119191193 | 11919119 | 10 | SS | ASPIRIN. | ASPIRIN | 1 | Unknown | U | 0 | UNSPECIFIED | |||||||||
| 119191193 | 11919119 | 11 | SS | CLOPIDOGREL | CLOPIDOGREL BISULFATE | 1 | Unknown | Y | 0 | UNSPECIFIED | |||||||||
| 119191193 | 11919119 | 12 | C | BISACODYL. | BISACODYL | 1 | Unknown | 0 | UNSPECIFIED | ||||||||||
| 119191193 | 11919119 | 13 | C | PANTOPRAZOLE | PANTOPRAZOLE SODIUM | 1 | Unknown | 0 | UNSPECIFIED | ||||||||||
| 119191193 | 11919119 | 14 | C | INVASTIN | 2 | Unknown | 0 | UNSPECIFIED | |||||||||||
| 119191193 | 11919119 | 15 | C | PRAMIPEXOLE. | PRAMIPEXOLE | 1 | Unknown | 0 | UNSPECIFIED | ||||||||||
| 119191193 | 11919119 | 16 | C | SPIRONOLACTONE. | SPIRONOLACTONE | 1 | Unknown | 0 | UNSPECIFIED | ||||||||||
| 119191193 | 11919119 | 17 | C | LEVOTHYROXIN | LEVOTHYROXINE | 1 | Unknown | 0 | UNSPECIFIED | ||||||||||
| 119191193 | 11919119 | 18 | C | METOPROLOL. | METOPROLOL | 1 | Unknown | 0 | UNSPECIFIED | ||||||||||
| 119191193 | 11919119 | 19 | C | LEVOTHYROXIN | LEVOTHYROXINE | 1 | Unknown | 0 | UNSPECIFIED | ||||||||||
| 119191193 | 11919119 | 20 | C | FUROSEMIDE. | FUROSEMIDE | 1 | Unknown | 0 | UNSPECIFIED |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 119191193 | 11919119 | 1 | Atrial fibrillation |
| 119191193 | 11919119 | 2 | Atrial fibrillation |
| 119191193 | 11919119 | 3 | Atrial fibrillation |
| 119191193 | 11919119 | 4 | Thrombosis prophylaxis |
| 119191193 | 11919119 | 5 | Thrombosis prophylaxis |
| 119191193 | 11919119 | 6 | Thrombosis prophylaxis |
| 119191193 | 11919119 | 7 | Cerebrovascular accident prophylaxis |
| 119191193 | 11919119 | 8 | Cerebrovascular accident prophylaxis |
| 119191193 | 11919119 | 9 | Cerebrovascular accident prophylaxis |
| 119191193 | 11919119 | 10 | Product used for unknown indication |
| 119191193 | 11919119 | 11 | Product used for unknown indication |
| 119191193 | 11919119 | 12 | Product used for unknown indication |
| 119191193 | 11919119 | 13 | Product used for unknown indication |
| 119191193 | 11919119 | 14 | Product used for unknown indication |
| 119191193 | 11919119 | 15 | Product used for unknown indication |
| 119191193 | 11919119 | 16 | Product used for unknown indication |
| 119191193 | 11919119 | 17 | Product used for unknown indication |
| 119191193 | 11919119 | 18 | Product used for unknown indication |
| 119191193 | 11919119 | 19 | Product used for unknown indication |
| 119191193 | 11919119 | 20 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 119191193 | 11919119 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 119191193 | 11919119 | Epistaxis | |
| 119191193 | 11919119 | Haemorrhage | |
| 119191193 | 11919119 | Haemorrhagic stroke |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 119191193 | 11919119 | 1 | 20151219 | 2015 | 0 | |
| 119191193 | 11919119 | 2 | 20141211 | 20141224 | 0 | |
| 119191193 | 11919119 | 5 | 20151219 | 2015 | 0 | |
| 119191193 | 11919119 | 6 | 20141211 | 20141224 | 0 | |
| 119191193 | 11919119 | 7 | 20141211 | 20141224 | 0 | |
| 119191193 | 11919119 | 9 | 20151219 | 2015 | 0 |